Medical abortion: A safe and effective alternative to surgical methods
Alison Santana
Writer's comment:
When I was first assigned to do a review paper I had no idea what I was
going to write about. There were so many topics I was interested in
that trying to decide on just one that was specific enough for the
paper was tough. I was reading some old scientific news articles to see
if anything appealed to me when I came across an article on RU-486,
also known as medical abortion. As I read the article, I decided that
this was something that not only interested me but also seemed to be a
topic of great importance to the general public. For these reasons I
decided to investigate medical abortion’s effectiveness compared to the
more traditional surgical methods. With so much recent negative
publicity, I was surprised and relieved to come to the conclusion,
through my research on the topic, that medical abortion is indeed a
safe alternative. I enjoyed writing this paper because it allowed me
the opportunity to research extensively a topic that intrigued me while
improving my researching techniques at the same time.
—Alison Santana
Instructor's comment: This
fine paper reviewing the literature on medical abortion was written in
English 104E (Science Writing), in response to my standard assignment
to write a scientific review article. Very often, students write papers
on topics that would be somewhat obscure to an audience of general
readers. Interestingly, Alison chose to write on a topic that is
regularly in the news: the effectiveness and safety of medical
abortion. As a writer concerned with the science, not the politics, of
abortion, Alison wisely sidesteps the controversy, focusing instead on
assessing the latest research on the effectiveness and safety of the
procedure. This is a paper that has multiple appeals: its discussion of
the pros and cons of mifepristone vs. gemeprost (for example) appeals
to an audience of researchers, but its analysis of clinical
studies—including some that look at the extent to which women are
satisfied with their experiences—appeals to anyone with an interest in
women’s health. All in all, this is an extremely interesting, balanced
analysis of the research.
—Pamela Demory, University Writing Program
Abstract
Medical abortion in the U.S. currently consists of a combination of two
drugs, mifepristone and misoprostol. Several studies have shown that
medical abortion is effective and that most women have been satisfied
with its results. In some countries, gemeprost is used instead of
misoprostol, which some studies have shown is less effective. Most side
effects of medical abortion are relatively mild; they include nausea,
vomiting, and dizziness. Current studies also indicate that a medical
abortion has no effect on the birth weight or the occurrence of
malformations in future wanted pregnancies. Still other researchers in
the field have conducted studies to compare medical abortion with the
surgical method. They found that both methods are effective and
acceptable, although at this time which one is the best is unclear.
Instead, these reports have emphasized the importance of allowing women
to choose which method suits them best. In addition to offering an
alternative to surgical abortion, medical abortion is a possible
solution in rural areas that do not have access to or cannot afford
surgical abortion. Future research on medical abortion should focus on
perfecting dosages to further improve this already effective option.
Introduction
Mifepristone use in medical abortions with gestational age less than 49
days was approved for use in the United States in September 2000 (1);
since then, millions of women in the U.S. have had medical abortions.
Mifepristone works by blocking progesterone receptors necessary for the
continuation of the pregnancy. It is most often used in conjunction
with miso-prostol or gemeprost, prostaglandin E1 analogues, which help
stimulate contractions in the smooth muscle of the uterus (2). As
medical abortion becomes an increasingly popular choice among women, it
is necessary to study the effectiveness and the side effects associated
with this method.
Some of the current research involves studying medical
abortion drugs to find the most efficient dose and method of
administration that maximizes the effectiveness and minimizes the side
effects. Some of these potential side effects include nausea, vomiting,
and diarrhea (2–5). Since medical abortion is offered as an alternative
to surgical abortion, much of the current research has compared the
costs and benefits of the two options. Some researchers have chosen to
perform stu-dies that compare the effectiveness, the occurrence of side
effects, and the satisfaction with the different procedures (9,10).
Other research concerns the effects that a medical abortion may have on
future wanted pregnancies (7,8).
Effectiveness of mifepristone in combination with either misoprostol or gemeprost
Multiple studies conducted all over the world have shown that the use
of mifepristone along with either gemeprost or miso-prostol in medical
abortion is effective in terminating early pregnancies. After women
were admitted into these studies, the gestational age of the embryo was
determined by calcula-tions based on their last menstrual period, a
pelvic examination, a blood sample (5), an ultrasound (3,4,5) or some
combination of these (2). In all of these studies, 200 mg of
mifepristone was given orally, while the dose and method of
administration for the prostaglandin varied (2–5). Effectiveness in
these studies was measured as the percentage of complete abortions,
which is defined as the passing of the placenta without the need for
further surgical intervention. In these tri-als, effectiveness rates
ranged from 90% to 98.7%, with varia-tions often being attributed to
the different doses and methods of administration of the prostaglandin
analogue (2–5).
Currently the prostaglandin used most often in other
countries is gemeprost (2). However, misoprostol, which is relatively
new to the market, is becoming an increasingly pop-ular choice because,
unlike gemeprost, it is cheap, can be taken orally, and can be stored
at room temperature (2,4,11). These factors are especially important in
rural and economi-cally disadvantaged areas where women may not have
easy access to surgical abortion and must therefore rely on an
af-fordable medical abortion alternative. Also of importance are the
results of a large study by Bartley et al. (2001), which showed that
the rate of complete abortion was higher in the treatment with
misoprostol (98.7%) than with gemeprost (96.2%) (2). This same study
showed that women who used gemeprost suffered more repeated episodes of
both diarrhea and vomiting, two of the relatively common side effects
asso-ciated with medical abortion (2).
In addition to comparing the different prostaglandins
available, researchers also wanted to compare the effective-ness of the
different modes of administration of misoprostol, including oral,
sublingual, and vaginal administration. A study by Tang et al. (2003)
found that complete abortion occurred more often in women who received
sublingual misoprostol than among those who received vaginal
misoprostol (98.2% vs. 93.8%), although the differences were not
statistically sig-nificant. One potential explanation for this
difference is that in sublingual administration it is easier to detect
whether or not the drug has been dissolved, which must occur for
misoprostol to enter the body (4). Another benefit of the sublingual
ad-ministration is that it is often less physically uncomfortable for
the woman. Also, because it does not require medical per-sonnel to
administer it, women can take it in the comfort of their home and avoid
the additional costs of returning to a clinic. Even so, a different
study, conducted by Schaff et al. (2001), found that oral
administration of misoprostol was only 95% effective, while the vaginal
administration was 99% effec-tive, a statistically significant
difference. Although the FDA currently recommends using oral
misoprostol, the researchers of this study suggest that the vaginal
method is more effective and should therefore be the recommended
procedure (5). While the different methods of administration all seem
to be successful, the different rates of effectiveness for different
methods show that more research must be done to pinpoint the best
dosage.
Comparison to surgical abortion
Since medical abortion is a newer alternative to surgical abor-tion,
many recent studies have been done to compare both the effectiveness
and satisfaction of one method versus the other. The purpose of these
studies is to gain valuable information not only of the effectiveness
and satisfaction of both methods, but also information about why
certain women choose certain methods (9,10). This information can be
extremely useful to health care providers, allowing them to provide
better coun-seling to their patients. Two studies, by Harvey et al.
(2001) and Rørbye et al. (2004), exemplify this trend. As these
stu-dies show, medical and surgical abortions were both effective and
acceptable, as determined by questionnaires that patients filled out
both before and after their procedures. There was a statistically
significant difference in the success rate of surgical abortion, which
was over 97% effective (10). However, as the questionnaires showed
researchers, other factors are involved in making the decision of which
method to use besides just the effectiveness.
As determined in both the Harvey et al. and the Rørbye et
al. studies, about 80% of women who underwent medical abortion answered
that they were very satisfied or at least somewhat satisfied with the
overall procedure (9,10). The Harvey et al. study, which was conducted
in the U.S. in 1998, found that satisfaction with the surgical option
was similar to that for the medical option (~82%) (9). However, the
study by Rørbye et al., conducted in 2001 in Denmark, found that the
satisfaction rates for surgical abortion were significantly higher than
those for medical abortion (92% vs. 79%) (10). There were slight
differences in the methods of the studies, including the use of
gemeprost instead of misoprostol in the Rørbye et al. study, which
other studies have shown to be less effective than misoprostol, and
this therefore may have had an effect on the study’s overall
satisfaction rating for medical abortion (2). The fact that the study
took place in another country with dif-ferent values and lifestyles may
also play a part in the Rørbye et al. study’s results. For example, the
acceptability of abor-tion in any given country may have a strong
influence on the number of abortions performed as well as the methods
used for the procedure. Regardless of these discrepancies, re-searchers
in both studies agree that it is very important for women to have a
choice of various methods. As the ques-tionnaires showed, women wanting
an abortion have many different views on life and have had varying past
experiences that may cause them to prefer one method over the other,
re-gardless of effectiveness and satisfaction rates of past studies
(9,10). Factors such as education level, occupation, age, and previous
abortions may be influential in these decisions.
Side effects
As the Harvey et al. study shows, a proportion of the women who chose
surgical over medical abortion did so because of the potential side
effects associated with medical abortion. Some of these potential side
effects include cramping, heavy bleeding, nausea, vomiting, diarrhea,
fever/chills, and dizziness (4,5,10). The most common side effects are
cramping and abdominal pain, which are caused by the body’s expulsion
of the placenta (4,5). While vomiting and diarrhea were also relatively
common side effects, most women suffered only a single episode.
However, in the study where gemeprost was used, reoccurring episodes
were more common (2). Although the contraction of the uterus caused by
misoprostol and ge-meprost is very important in the expulsion of the
placenta, un-fortunately it can also affect the rest of the body in
some of the ways listed above (2).
Other severe but infrequent side effects include prolonged
heavy bleeding and pelvic infection (2,11). Women who at any point in
their lives suffered ectopic pregnancies were ex-cluded from most
studies due to the increase in complications that often occurs if a
woman with an ectopic pregnancy un-dergoes medical abortion treatment
(2,10). Other issues such as asthma, liver or kidney impairment,
anemia, heavy smok-ing, or coagulant problems also excluded women from
the study due to the increase in the occurrence of serious side
ef-fects (2,5,10). Medical abortion is rarely recommended for women who
are not in good health.
Some women fear that medical abortion may adversely affect
future pregnancies. Two large studies were conducted in China to
determine whether medical abortions or surgical abortions affected
future wanted pregnancies. This was es-pecially of interest to
researchers there because medical abor-tion has been legal since 1988
and yet very little research has been done on this issue (7,8). The
focus of both the Chen et al. study (2004) and the Yimin et al. study
(2004) was to iden-tify the effects of previous abortions on the birth
weight of fu-ture children. Both studies confirmed that a previous
medical abortion or a previous surgical abortion had no effect on the
birth weight of future pregnancies (7,8). The majority of women who
underwent previous medical abortions received mifepristone and
misoprostol regimens similar to the regimens given to the women in the
other studies reviewed in this paper. Surprisingly, the Chen et al.
study also found that the mean birth weights of babies from women who
had previously un-dergone medical abortion were higher than those
babies whose mothers had not undergone previous abortions, although the
differences were not statistically significant (7). The same study also
found that women who had undergone either a medical or surgical
abortion in the past were less likely to go into labor early, and it
found no difference in the rates of malformation between the groups
(7). These are extremely important and reassuring results for women who
are consider-ing having (or have already undergone) a medical abortion,
yet who later in life might want children.
Conclusion
The use of mifepristone and misoprostol in medical abortions has become
an increasingly popular alternative to surgical abortion all over the
world. As millions of women choose this abortion method, the question
of effectiveness and side effects becomes extremely important. Current
research has shown that not only is medical abortion effective, but
that most wom-en who choose this method are satisfied with the results
(2–5,10,11). While there are some side effects associated with medical
abortion, many of them are mild and may seem unimportant in comparison
to the benefits, such as the comfort of being in your home during the
procedure (4,5,10). As medical abortion increasingly replaces surgical
abortions, re-searchers interested in studying the differences between
the two methods have found that both methods are effective, al-though
the satisfaction rates vary somewhat between the stu-dies (9,10).
While studies have shown that medical abortion is
effec-tive, the actual percentages vary rather interestingly between
studies, from 90% to 98.7%. This is often due to the different drugs or
dosages used. Some studies used mifepristone and misoprostol, while
others replaced misoprostol with another prostaglandin, gemeprost.
Also, the drugs used were admi-nistered in a variety of ways, including
orally, sublingually, and vaginally. Given the many variations seen in
these proce-dures, current research should be focused on finding the
best dosage and method of administration for medical abortion, one that
yields high and consistent effectiveness rates with a low occurrence of
side effects. This will allow women all over the world to have a safe
and reliable alternative to the more inva-sive surgical abortion
procedure.
Literature Cited
(1) U.S. Food and Drug Administration. 2004. Mifeprex (mifepris-tone) Information. Feb 2, 2005.< http://www.fda.gov/cder/drug/infopage/mifepristone/default.htm>(2) Bartley, J., Brown, A., Elton, R., Baird, D. T. 2001. Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation. Human Reproduction 16: 2098–2102.
(3) Schaff, E. A., Fielding, S. L., Westhoff, C. 2001. Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion. Contraception 64: 81–85.
(4) Tang, O. S., Chan, C. C. W., Ng, E. H. Y., Lee, S. W. H., Ho, P. C. 2003. A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation. Human Reproduction 18: 2315–2318.
(5) Xiou, B., Hertzen, H., Zhao, H., Piaggio, G. 2003. Menstrual induction with mifepristone and misoprostol. Contraception 68: 489–494.
(6) Schaff, E. A., Fielding, S. L., Eisinger, S., Stadalius, L. 2001. Mifepristone and misoprostol for early abortion when no gesta-tional sac is present. Contraception 63: 251–254.
(7) Chen, A., Yuan, W., Meirik, O., Wang, X., Wu, S. Z., Zhou, L., Luo, L., Gao, E., Cheng, Y. 2004. Mifepristone-induced early abortion and outcome of subsequent wanted pregnancy. American Journal of Epidemiology 160: 2.
(8) Yimin, C., Wei, Y., Weidong, C., Xianmi, W., Junqing, W., Lin, L. 2004. Mifepristone-induced abortion and birth weight in the first subsequent pregnancy. International Journal of Gynecol-ogy and Obstetrics 84: 229–235.
(9) Harvey, S. M., Beckman, L. J., Satre, S. J. 2001. Choice of and satisfaction with methods of medical and surgical abortion among U.S. clinic patients. Family Planning Perspectives 33: 212–216.
(10) Rørbye, C., Nørgaard, M., Nilas, L. 2004. Medical versus surgical abortion: comparing satisfaction and potential con-founders in a partly randomized study. Human Reproduction 20(3): 834–8.
(11) Ashok, P. W., Templeton, A., Wagaarachchi, P.T., Flett, G. M. M. 2004. Midtrimester medical termination of pregnancy: A review of 1002 consecutive cases. Contraception 69: 51–58.
(12) Wiebe, E., Dunn, S., Guilbert, E., Jacot, F., Lugtig, L. 2002. Comparison of abortions induced by methotrexate or mifepris-tone followed by misoprostol. Obstetrics and Gynecology 99:813–819.